Polymorphism of the angiotensin I-converting enzyme gene in diabetic nephropathy in type II diabetic patients with proliferative retinopathy

Renal Failure

Volumn 20, Issue 1, 1998, Pages 125-133

  Hanyu, Osamu ^a   Hanawa, Haruo ^a   Nakagawa, Osamu ^a   Tani, Nagayuki ^a   Andou, Noburo ^a   Aizawa, Yoshifusa ^a   Shibata, Akira ^a  

^a NIIGATA UNIVERSITY   (Japan)

Author keywords

Angiotensin I Converting Enzyme; Diabetic Nephropathy; Diabetic Proliferative Retinopathy; Gene Polymorphism; Type II Diabetes Mellitus

Indexed keywords

ANGIOTENSIN I; DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; DIABETIC NEPHROPATHY; DISEASE PREDISPOSITION; DNA POLYMORPHISM; ENZYME ACTIVATION; FEMALE; GENE DELETION; GENE INSERTION; GLUCOSE BLOOD LEVEL; HUMAN; INTRON; MALE; MICROANGIOPATHY; PRIORITY JOURNAL; PROLIFERATIVE RETINOPATHY;

EID: 0031887169     PISSN: 0886022X     EISSN: None     Source Type: Journal    
DOI: 10.3109/08860229809045095     Document Type: Article

References (23)

1. Nielsen NV: Diabetic retinopathy II. The course of retinopathy in diabetics treated with oral hypoglycemic agents and diet regime alone: A one year epidemiologic cohort study of diabetes mellitus: The Island of Faister, Denmark. Acta Ophthalmologica 62:266-273, 1984.
2. Krolewski AS, Warram JR, Christlieb AR, Busick EJ, Kahn CR: The changing natural history of nephropathy in type 1 diabetes Am J Med 78:785-794, 1985.
3. Dorf A, Ballintine EJ, Bennett PH, Miller M: Retinopathy in Pima Indians: Relationships to glucose level, duration of diabetes, age at diagnosis, and age at examination in a population with a high prevalence of diabetes mellitus. Diabetes 25:554-560, 1976.
4. Kunuiman MW, Welborn TA, McCann VJ, Stanton KG, Constable IJ. Prevalence of diabetic complications in relation to risk factors Diabetes 35:1332-1339, 1986.
5. Pettitt DJ, Saad MF, Bennett PH, Nelson RG, Knowler WC: Familial predisposition to renal disease in two generations of Pima Indians with Type 2 (non-insulin-dependent) diabetes mellitus Diabetologia 33:438-443, 1990.
6. Krolewski AS, Cannesa M, Warram JH, Laffel LM, Christlieb AR,Knowler WC, Rand LI: Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus. N Engl J Med 318 140-145, 1988.
7. Cambien F, Poirier O, Lecerf L, Evans A, Cambous JP, Arveiler D, Luc O, Bard JM, Bara L, Ricard S, Tiret L, Amouyel P, Gelas FA, Soubrier F: Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 359:641-644, 1992
8. Marre M, Bernadet P, Gallois Y, Savagner F, Guyene TT, Hallab M, Cambien F, Passa P, Gelas FA Relationships between Angiotensin J converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications. Diabetes 43 38-388, 1994
9. Schmidt S, Schone N, Ritz E, and the diabetic nephropathy study Group: Association of ACE gene polymorphism and diabetic nephropathy? Kidney Int 47 1176-1181, 1995.
10. Tarnow L, Cambien F, Rossing P, Nielsen F, Hansen BV, Lecerf L,Poirier O, Danilov S, Parving HR: Lack of relationship between an Insertion/Deletion polymorphism in the angiotensin I-Converting enzyme gene and diabetic nephropathy and proliferative retinopathy in IDDM patients. Diabetes 44:489-494, 1995.
11. 2-macroglobulin in type 2 diabetic patients. Horm Metab Res 27:303-304, 1995.
12. Yamazaki M, Ito S, Usami A, Tani N, Hanyu O Nakagawa O Nakamura H, Shibata A: Urinary excretion rate of ceruloplasmin in non-insulin-dependent diabetic patients with different stages of nephropathy. European J Edocrinol 132:681-687, 1995
13. The diabetes control and complications trail research group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329; 14:977-986, 1993.
14. Berkman J, Rifkin H: Unilateral nodular diabetic Glomerulosclerosis (Kimmelstiel Wilson). Report of a case Metabolism 22:715-722, 1973.
15. Mogensen CE: Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy. Br Med J 285:685-688, 1982.
16. Josefsberg Z, Ross SA, Lev-Ran A, Hwang DL: Effects of Enalapril and nitrendi pine on the excretion of epidermal growth factor and albumin in hypertensive NIDDM patients. Diabetes Care 18:690-693, 1995.
17. Nielsen FS, Rossing P, Gall MA, Skott P, Smidt UM, Parving RH: Impact of lisinopril and atenolol on kidney function in hypertensive NIDDM subjects with diabetic nephropathy. Diabetes 43(9): 1108-1113, 1994.
18. Rudberg S, Aperia A, Freyschuss U, Persson B. Enalapril reduces microalbuminuria in young normotensive type 1 (insulin-dependent) diabetic patients irrespective of its hypotensive effect. Diabetologia 33:470-476, 1990.
19. Allen TJ, Huithen UL, Rumble JA, Cooper ME: Diabetic vascular hypertrophy and albuminuria: Effect of angiotensin converting enzyme inhibition. J Diabetes and Its Complications 9:4:318-322, 1995.
20. Hansen PM, Mathiesen ER, Enevoldsen AK, Deckert T. Possible effect of angiotensin-converting enzyme inhibition on glomerular charge selectivity. J Diabetes and Its Complications 9:158-162, 1995.
21. Panagiotopoulas S, Smith TJ, Aldred GP, Baker EJ, Jacklin CJ, Jerums G: Angiotensin-converting enzyme (ACE) gene polymorphism in type II diabetic patients with increased albumin excretion rate. J Diabetes and Its Complications 9:4:272-276, 1995.
22. Fujisawa T, Ikegami H, Shen GQ, Yamato E, Takekawa K, Nakagawa Y, Hamada Y, Ueda H, Rakugi H, Higaki J: Angiotensin I-Converting enzyme gene polymorphism is associated with myocardial infarction but not with retinopathy of nephropathy, in NIDDM. Diabetes Care 18:983-985, 1995.
23. Higashimori K, Zhao Y, Higaki J, Kamitani A, Katsuya T, Nakuraj, Miki T, Mikami H, Ogihara T: Association analysis of a polymorphism of the angiotensin converting enzyme gene with essential hypertension in the Japanese population. Biochem Biophys Res Comm 191:399-404, 1993.